A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia - Gera, Kriti; Cline, Christina; Al-Mansour, Zeina; Medvec, Andrew; Lee, Ji-Hyun; Galochkina, Zhanna; Hsu, Jack; Hiemenz, John; Farhadfar, Nosha; Dean, Erin A.; Wingard, John R.; Brown, Randy (Leukemia & lymphoma, 2024)
Keywords: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Ciprofloxacin - administration & dosage; Ciprofloxacin - adverse effects; Ciprofloxacin - therapeutic use; Drug Resistance, Neoplasm - drug effects; Etoposide - administration & dosage; Etoposide - adverse effects; Female; Humans; Leukemia, Myeloid, Acute - diagnosis; Leukemia, Myeloid, Acute - drug therapy; Male; Maximum Tolerated Dose; Middle Aged; Treatment Outcome; clinical trial; etoposide; maximum tolerated dose; adverse events; Acute myeloid leukemia; ciprofloxacin